Patients treated with dose-dense chemotherapy did not show signs of improvement with oral bisphosphonates. Other studies have shown bisphosphonates are beneficial for patients receiving endocrine treatment. Results do not confirm the use of bisphosphonates in the adjuvant setting. SAN ANTONIO — Results from a German study demonstrated no improvement in disease-free survival among patients with [...]
Read the complete post at http://aacrnews.wordpress.com/2011/12/07/oral-bisphosphonate-did-not-improve-prognosis-for-patients-with-breast-cancer/
Posted
Dec 07 2011, 04:00 PM
by
AACR News
Filed under: Press Releases, Research, Breast Cancer, Conference, Cancer, teleconference, Media Materials, AACR, American Association for Cancer Research, women, meeting, CTRC-AACR San Antonio Breast Cancer Symposium, CTRC, press conference, San Antonio Breast Cancer Symposium, SABCS, Baylor College of Medicine, Volker Möbus, oral bisphosphonate